Video

Dr. Donington on the Role of Neoadjuvant Immunotherapy in Stage II NSCLC

Jessica Donington, MD, MSCR, discusses the role of neoadjuvant immunotherapy in patients with stage II non–small cell lung cancer. 

Jessica Donington, MD, MSCR, professor of surgery and chief of the Section of Thoracic Surgery at the University of Chicago Medicine, discusses the role of neoadjuvant immunotherapy in patients with stage II non–small cell lung cancer (NSCLC).

Trials evaluating neoadjuvant immunotherapy in NSCLC included patients with stage II and stage III disease, says Donington. However, its role in patients with stage II disease is unclear.

It is not standard of care to give patients with stage II disease neoadjuvant chemotherapy prior to surgical resection, explains Donington. Instead, these patients typically undergo resection followed by adjuvant chemotherapy.

Until the field has long-term data with neoadjuvant immunotherapy, patients with stage II disease should continue to undergo up-front surgical resection, concludes Donington.

Related Videos
Julia Rotow, MD, clinical director, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; assistant professor, medicine, Harvard Medical School
Alastair Thompson, BSc, MBChB, MD, FRCS
C. Ola Landgren, MD, PhD
Sara M. Tolaney, MD, MPH
Adam M. Brufsky, MD, PhD, FACP
Justin M. Watts, MD
Sara M. Tolaney, MD, MPH
Leah Backhus, MD, MPH, FACS, professor, University Medical Line, Cardiothoracic Surgery, co-director, Thoracic Surgery Clinical Research Program, associate program director, Thoracic Track, CT Surgery Residency Training Program, Thelma and Henry Doelger Professor of Cardiovascular Surgery, Stanford Medicine; chief, Thoracic Surgery, VA Palo Alto
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Medical Oncology, director, Center for Thoracic Cancers, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Chirag Shah, MD